The Conflicts Committee engaged Potter Anderson & Corroon LLP as its legal advisor and Evercore as its financial advisor. Gibson, Dunn & Crutcher LLP assisted Evercore....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers involved in the offering, while Gibson Dunn and Van Campen Liem advised Expro. The selling shareholders were assisted by...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters and placements agents in the transaction. Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Canoo, while Davis Polk advised the sales agents in the offering. Canoo, Inc. executed its at-the-market offering of shares of its common stock for...
You must be a Standard 1 Year member to access this content.
Cooley represented Mirum Pharmaceuticals, while Latham & Watkins represented the underwriters in the offering. Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation. Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Kennedy-Wilson, while Davis Polk advised the sales agents in the transaction. Kennedy-Wilson Holdings, Inc. announced its SEC-registered at-the-market offering program under which Kennedy-Wilson may...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Davis Polk advised CCC Intelligent Solutions Holdings, while the representatives of the several underwriters in the offering. CCC Intelligent Solutions Holdings Inc....
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the offering. Travere Therapeutics, Inc. executed its offering of US$275 million aggregate principal amount of 2.25% convertible senior notes due...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Pfizer Inc. in the deal, while Cooley represented Arena Pharmaceuticals. Debevoise & Plimpton advised Evercore Group and Guggenheim Securities as financial advisors...
You must be a Standard 1 Year member to access this content.
